BACKGROUND: Understanding the comorbidity of alcohol use disorder (AUD) and other psychiatric diagnoses has been a long-standing interest of researchers and mental health professionals. Comorbidity is often examined via the diagnostic co-occurrence of discrete, categorical diagnoses, which is incongruent with increasingly supported dimensional approaches of psychiatric classification and diagnosis, and for AUD more specifically. The present study examined associations between DSM-5 AUD and psychiatric symptoms of other DSM-IV and DSM-5 disorders categorically, and dimensionally organized according to the Hierarchical Taxonomy of Psychopathology (HiTOP) spectra (e.g., Internalizing, Disinhibited Externalizing). METHODS: The comorbidity of AUD with other psychological disorders was examined in 2 independent nationally representative samples of past-year drinkers via an initial examination in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) Wave 2 and replicated in NESARC-III. RESULTS: Analyses focusing on psychopathology symptom counts organized by spectra demonstrated that greater AUD severity was associated with a higher number of symptoms across HiTOP spectra. Traditional categorical analyses also demonstrated increasing prevalence as a monotonic function of DSM-5 AUD severity gradients. CONCLUSIONS: This study indicates that AUD and other psychiatric disorder comorbidity implies increased presence of multiple forms of psychopathology with a corresponding increased number of symptoms across hierarchical spectra. Greater AUD severity increases the likelihood of other psychopathology and, when present, "more severe" presentations. That is, on average, a given disorder (e.g., depression) is more severe when copresenting with an AUD, and increases in severity along with the AUD.
BACKGROUND: Understanding the comorbidity of alcohol use disorder (AUD) and other psychiatric diagnoses has been a long-standing interest of researchers and mental health professionals. Comorbidity is often examined via the diagnostic co-occurrence of discrete, categorical diagnoses, which is incongruent with increasingly supported dimensional approaches of psychiatric classification and diagnosis, and for AUD more specifically. The present study examined associations between DSM-5 AUD and psychiatric symptoms of other DSM-IV and DSM-5 disorders categorically, and dimensionally organized according to the Hierarchical Taxonomy of Psychopathology (HiTOP) spectra (e.g., Internalizing, Disinhibited Externalizing). METHODS: The comorbidity of AUD with other psychological disorders was examined in 2 independent nationally representative samples of past-year drinkers via an initial examination in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) Wave 2 and replicated in NESARC-III. RESULTS: Analyses focusing on psychopathology symptom counts organized by spectra demonstrated that greater AUD severity was associated with a higher number of symptoms across HiTOP spectra. Traditional categorical analyses also demonstrated increasing prevalence as a monotonic function of DSM-5 AUD severity gradients. CONCLUSIONS: This study indicates that AUD and other psychiatric disorder comorbidity implies increased presence of multiple forms of psychopathology with a corresponding increased number of symptoms across hierarchical spectra. Greater AUD severity increases the likelihood of other psychopathology and, when present, "more severe" presentations. That is, on average, a given disorder (e.g., depression) is more severe when copresenting with an AUD, and increases in severity along with the AUD.
Authors: Robert F Krueger; Roman Kotov; David Watson; Miriam K Forbes; Nicholas R Eaton; Camilo J Ruggero; Leonard J Simms; Thomas A Widiger; Thomas M Achenbach; Bo Bach; R Michael Bagby; Marina A Bornovalova; William T Carpenter; Michael Chmielewski; David C Cicero; Lee Anna Clark; Christopher Conway; Barbara DeClercq; Colin G DeYoung; Anna R Docherty; Laura E Drislane; Michael B First; Kelsie T Forbush; Michael Hallquist; John D Haltigan; Christopher J Hopwood; Masha Y Ivanova; Katherine G Jonas; Robert D Latzman; Kristian E Markon; Joshua D Miller; Leslie C Morey; Stephanie N Mullins-Sweatt; Johan Ormel; Praveetha Patalay; Christopher J Patrick; Aaron L Pincus; Darrel A Regier; Ulrich Reininghaus; Leslie A Rescorla; Douglas B Samuel; Martin Sellbom; Alexander J Shackman; Andrew Skodol; Tim Slade; Susan C South; Matthew Sunderland; Jennifer L Tackett; Noah C Venables; Irwin D Waldman; Monika A Waszczuk; Mark H Waugh; Aidan G C Wright; David H Zald; Johannes Zimmermann Journal: World Psychiatry Date: 2018-10 Impact factor: 49.548
Authors: Wendy S Slutske; Andrew C Heath; Pamela A F Madden; Kathleen K Bucholz; Dixie J Statham; Nicholas G Martin Journal: J Abnorm Psychol Date: 2002-02
Authors: Oleguer Plana-Ripoll; Carsten Bøcker Pedersen; Yan Holtz; Michael E Benros; Søren Dalsgaard; Peter de Jonge; Chun Chieh Fan; Louisa Degenhardt; Andrea Ganna; Aja Neergaard Greve; Jane Gunn; Kim Moesgaard Iburg; Lars Vedel Kessing; Brian K Lee; Carmen C W Lim; Ole Mors; Merete Nordentoft; Anders Prior; Annelieke M Roest; Sukanta Saha; Andrew Schork; James G Scott; Kate M Scott; Terry Stedman; Holger J Sørensen; Thomas Werge; Harvey A Whiteford; Thomas Munk Laursen; Esben Agerbo; Ronald C Kessler; Preben Bo Mortensen; John J McGrath Journal: JAMA Psychiatry Date: 2019-03-01 Impact factor: 21.596
Authors: Leonieke C van Boekel; Evelien P M Brouwers; Jaap van Weeghel; Henk F L Garretsen Journal: Drug Alcohol Depend Date: 2013-03-13 Impact factor: 4.492
Authors: Carolina Hanna Chaim; Geilson Lima Santana; Paula de Vries Albertin; Camila Magalhães Silveira; Erica Rosanna Siu; Maria Carmen Viana; Wang Yuan Pang; Laura Helena Andrade Journal: PLoS One Date: 2021-03-23 Impact factor: 3.240
Authors: Samuel W Stull; Jeremiah W Bertz; David H Epstein; Bethany C Bray; Stephanie T Lanza Journal: J Addict Med Date: 2022 May-Jun 01 Impact factor: 4.647